Get the tools used by (smart)2 investors.
SP500 -0.2%DOW -0.1%FTSE 100 0.4%NIKKEI -0.0%OIL 0.1%GOLD -0.8%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Capital Expenditures for Retractable Technologies Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

RVP: Retractable Technologies Inc

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and Sout...

- USD
Price
– USD
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Retractable Technologies Inc's Capital Expenditures:

Dec 2015Dec 2017Dec 2019Dec 2021Dec 202310 M30 M50 M70 M
Performance Summary
  • Retractable Technologies's latest twelve months capital expenditures is 1.296 million
  • Retractable Technologies's capital expenditures for fiscal years ending December 2019 to 2023 averaged 19.546 million.
  • Retractable Technologies's operated at median capital expenditures of 16.83 million from fiscal years ending December 2019 to 2023.
  • Looking back at the last 5 years, Retractable Technologies's capital expenditures peaked in December 2021 at 58.367 million.
  • Retractable Technologies's capital expenditures hit its 5-year low in December 2019 of 632.078 thousand.
  • Retractable Technologies's capital expenditures decreased in 2022 (16.83 million, -71.2%) and 2023 (852.979 thousand, -94.9%) and increased in 2019 (632.078 thousand, +65.4%), 2020 (21.05 million, +3,230.2%), and 2021 (58.367 million, +177.3%).

How does Retractable Tech's Capital Expenditures benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Retractable Technologies Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Retractable Tech Capital Expenditures Benchmarks
NameTickerCapital Expenditures
Neuroone Medical Technologies CorpNASDAQCM:NMTC107.482 K
Precision Optics Corporation IncNASDAQCM:POCI174.365 K
Cytosorbents CrpNASDAQCM:CTSO310.655 K
Sight Sciences IncNASDAQGS:SGHT385 K
Zynex IncNASDAQGS:ZYXI578 K
HealthcareSECTOR:HLTH.US660.333 K
Retractable Technologies IncNYSEAM:RVP1.296 M
Procept Biorobotics CorpNASDAQGM:PRCT4.409 M
Orthopediatrics CorpNASDAQGM:KIDS14.263 M
Embecta CorpNASDAQGS:EMBC14.6 M
Paragon 28 IncNYSE:FNA15.797 M
Edwards Lifesciences CorpNYSE:EW252.4 M

Metric Usage: Capital Expenditures

Hide this widget
capex
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Capital Expenditures in the financials category include:

View Full List

Search for metric or datapoint

Capital Expenditures

The overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sale...

Definition of Capital Expenditures

Hide this widget

Capital expenditures or CAPEX represents spending on assets that are enjoyed over a long period of time. Common examples of capital expenditures include office buildings, machines, and vehicles.

Capital expenditures can be found on a company’s cash flow statement under “Investing Activities” and increases fixed assets located on the Balance Sheet

Retractable Technologies reported capital expenditures of 1.296 M for the latest twelve months ending September 30, 2024 on its income statement.

The tables below summarizes Retractable Technologies’s capital expenditures and common size over the last five years:

Fiscal Year Capital Expenditures Revenue % Revenue
2019-12-31632.078 T41.797 M1.5%
2020-12-3121.05 M81.862 M25.7%
2021-12-3158.367 M188.4 M31.0%
2022-12-3116.83 M94.819 M17.7%
2023-12-31852.979 T43.597 M2.0%

The tables below summarizes Retractable Technologies’s capital expenditures and common size over the last four quarters:

Quarter Ending Capital Expenditures Revenue % Revenue
2023-12-31153.696 T14.29 M1.1%
2024-03-31226.396 T7.599 M3.0%
2024-06-30121.704 T6.029 M2.0%
2024-09-30793.785 T10.347 M7.7%
Click the link below to download a spreadsheet with an example Capital Expenditures calculation for Retractable Technologies Inc below:

Sector Benchmark Analysis

All rights reserved. Terms Of Use